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Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers.
Recent research has demonstrated that chronic pancreatitis (CP) is associated with
an increased risk of PDAC, partly due to acinar-to-ductal metaplasia (ADM).
Baicalein has been shown to exert anti-inflammatory and anti-tumor effects for CP
or PDAC, respectively. The aim of our study was to investigate the effect of
baicalein, and the putative underlying mechanism, on inflammatory cytokines-
induced ADM of rat pancreatic acinar cell line AR42J. To investigate ADM and
baicalein effects in vitro, AR42J were treated with recombinant rat Tumor
Necrosis Factor alpha (rTNFα) with or without baicalein for 5 days. Results
showed that rTNFα-induced AR42J cells switched their phenotype from
dominantly amylase-positive acinar cells to dominantly cytokeratin 19-positive
ductal cells. Moreover, expression of the transcripts for TNFα or Hes-1, a Notch
target, was up-regulated in these cells. Interestingly, baicalein reduced the
population of ADM as well as cytokines gene expression but not Hes-1. Baicalein
inhibited NF-κB activation induced by rTNFα in AR42J, but no effect on Notch
1activation. Moreover, baicalein suppressed the secretion of TNFα and Nitric
Oxide (NO) in macrophages stimulated with LPS and further inhibited ADM of
conditional medium-treated AR42J cells. Baicalein also suppressed the inflamma-
tory response of LPS-activated macrophages, thereby inhibited ADM of AR42J by
altering their microenvironment. Taken together, our study indicates that baicalein
reduces rTNFα-induced ADM of AR42J cells by inhibiting NF-κB activation. It also
sheds new light on Chinese material medica therapy of pancreatitis and thereby
prevention of PDAC.
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1 | INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive
cancer. Even with early diagnosis, nearly all patients die from the
disease within 1–2 years after diagnosis (Johnston et al., 2016).
The high mortality of full blown PDAC, calls for strategies for its
prevention. Many risk factors are associated with the development of
PDAC, the most common of which is pancreatitis (Li, Xie, Wolff, &
Abbruzzese, 2004). Clinical trials had shown that the incidence of
PDAC in patients with pancreatitis was greatly increased (Krejs, 2010;
Lowenfels & Maisonneuve, 2006). Recently, it has been shown that
inflammation contributes to development of PDAC as pancreatic
acinar cells may undergo transdifferentiation toward a ductal
phenotype (acinar-to-ductal metaplasia, ADM), progress to pancreatic
intraepithelial neoplasia (PanIN) and eventually form invasive PDAC
(Lardon & Bouwens, 2005; Shi et al., 2009). During pancreatitis, these
metaplasia duct-like cells dampen the expression of pancreatic
enzymes but increase the expression of keratin (Means & Logsdon,
2016). ADM was detected in patients with pancreatitis, in a model of
chronic pancreatitis (WBN/Kob rats) and in caerulein-induced
pancreatitis in mice, consistent with a role of the inflammatory
microenvironment in promoting tumorigenesis (Reding et al., 2009;
Seleznik et al., 2012). On the other hand, macrophage infiltration, and
the inflammatory response of pancreatic acinar cells can induce
pancreatic ADM and increase the incidence of PDAC (Helm et al.,
2014; Liou et al., 2013; Xue et al., 2015). Macrophage-derived
proinflammatory cytokines, such as TNFα, are potent drivers of ADM.
The root of Scutellaria baicalensis Georgi, listed in the Chinese
Pharmacopoeia, is one of the commonly used traditional Chinese herbs
for the treatment of pancreatitis in China and other East Asian
countries. Baicalein (5, 6, 7-trihydroxy-2-phenyl-4H-1-benzopyran-4-
one), one of its derived product, is a flavonoid with a defined chemical
structure, reported to possess excellent anti-inflammatory, and anti-
tumor activities (Gao, Snyder, Smith, & Chen, 2016). Baicalein could
alleviate experimental pancreatitis by inhibiting the expression of
pancreatic enzyme and cytokines via multiple pathways (Li et al.,
2015a, b). To the best of our knowledge, there are only a few previous
reports on the effects of baicalein on pancreatic ADM mainly focused
on its effect on apoptosis and proliferation (Cathcart et al., 2016; Chen
et al., 2014; Guo et al., 2015; He et al., 2017; Lian et al., 2017; Zhang
et al., 2013). Our study was initiated with the purpose to investigate
the effect of baicalein, and the putative mechanism involved, on ADM
induced by inflammatory cytokines, using the rat pancreatic acinar cell
line AR42J as in vitro model. Results issued from this study may
provide new sights into the potential role of baicalein in controlling
pancreatitis or prevention of PDAC.
2 | MATERIALS AND METHODS
2.1 | Cell lines, antibodies, and reagents
RAW264.7 murine macrophages cells, obtained from the Cell Culture
Center of the Chinese Academy of Medical Sciences (Beijing, China),
were maintained as described before (Sun, Wahl, Bilic, & Wuthrich,
2001). For the determination of NO and TNF-α concentrations, cells
were plated at a density of 2.5 × 105 cells/ml in 24-well plates for 24 hr
and then treated with LPS (0.5 μg/ml) in the presence or absence of
different concentrations of baicalein for 18 hr.
AR42J (ATCC® CRL-1492™) rat exocrine pancreas cells, obtained
from the American Type Culture Collection (ATCC, Manassas, VA),
were maintained as described before (Sun et al., 2007). For monitoring
AR42J phenotypical transdifferentiation and related gene and protein
expression, cells were routinely plated at a density of 8 × 104 cells/ml
in 12-well plates or on coverslips for 24 hr and then treated with
baicalein treated macrophage-conditional medium or recombinant rat
TNFα (50 ng/ml) in the presence or absence of baicalein (40 μM) for
5 days. Culture medium replaced every other day.
Recombinant rat TNFα (rTNFα) waspurchased fromPeproTech Inc.
(Rocky Hill, NJ). Primary antibodies against phosphorylated IκBα
(p-IκBα), IκBα, NF-κB, amylase, cytokeratin 19, and cleaved-Notch 1
were purchased from CST Inc. (Danvers, MA). Mouse TNFα DuoSet
ELISA kit was purchased from R&D Systems (Minneapolis, MN). Griess
Reagent was purchased from Beyotime Institute of Biotechnology
(Shanghai, China). Lipopolysaccharide (LPS)waspurchased fromSigma–
Aldrich (St Louis, MO). Baicalein (purity exceed 98%), purchased from
Top High Bio Technology Co., Ltd. (Nanjing, China), was dissolved in
dimethylsulfoxide (DMSO) and further diluted in cell culture medium.
The final DMSO concentration did not exceed 0.1% (v/v).
2.2 | Cell viability assay
Cell viability of AR42J or RAW264.7 treated with baicalein was
measured with MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide) test. After treatment with baicalein or rTNFα
for 5 days, cells were incubated with MTT reagent (dissolved in PBS at
a final concentration of 0.5 mg/ml) at 37°C for 4 hr. After rinsing of the
well, DMSO was added to all wells and mixed thoroughly to dissolve
the dark blue crystals. Plates were read on a Microplate Reader
(Molecular Devices, Sunnyvale, CA), at 570 nm wavelength against a
reference wavelength of 630 nm.
2.3 | Immunofluorescence staining
Cells were cultured on glass coverslips, washed with phosphate-
buffered saline (PBS) to remove serum, fixed with 4% paraformalde-
hyde (PFA), permeabilized with 0.2% Triton X–100 for 5min, and
blocked for nonspecific binding of IgG with 3% Bovine Serum Albumin
(BSA) for 30min. The specific primary antibodies, goat anti-rat amylase
and rabbit anti rat cytokeratin 19 were used at 1:200 and 1:200
dilutions in PBS, respectively and incubated at 4°C overnight. After a
washing step, the coverslips were incubated with FITC- or TRITC-
conjugated secondary antibody for 1 hr. DAPI solution (125 μg/ml)
was added when samples were incubated with the secondary
antibodies. The coverslips were washed three times in PBS.
Images were taken with Nikon TiU microscope (Nikon, Amstelveen,
Netherlands).
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2.4 | RNA isolation and real-time PCR
Total RNA was isolated from AR42J cells using TRIzol reagent
according to the manufacturer's instructions (Invitrogen Life Technol-
ogies, Carlsbad, CA). Total RNA samples were pretreated with DNase
to eliminate residual genomic DNA. Total RNA (2 μg) was reverse-
transcribed to cDNA using GoScript™ Reverse Transcription System
(Promega Corporation, Madison, WI) according to manufacturer's
instructions. Briefly, the reaction was incubated in steps of 25°C for
5min, 42°C for 60min, 70°C for 15min, and held at 4°C. Real-time RT-
PCR was performed using SYBR Green PCR Master Mix reagent kits
(Promega Corporation, Madison, WI), performed in a real-time C1000
Touch™ Thermal Cycler with a CFX96 real time system (Bio-rad,
Hercules, CA) with the following thermocycler program: 95°C for 20 s,
40 cycles of 95°C for 5 s, and 60°C for 60 s. Specific primer sets for rat
TNFα, Hes-1, and β-actin were as follows: TNFα: Forward: 5′-3′-
GAAGAGAACCTGGGAGTAGATAAGG, Reverse: 5′-3′-GTCGTAG-
CAAACCACCAAGC; Hes-1: Forward: 5′-3′-CAACACGACACCGGA-
CAAAC, Reverse: 5′-3′-GGAATGCCGGGAGCTATCTT; β-actin:
Forward: 5′-3′-GTGACGTTGACATCCGTAAAGA, Reverse: 5′-3′-
GCCGGACTCATCGTACTCC. The mRNA expression levels were
determined relative to a blank control after normalizing to β-actin
using the 2−△△CT method. Each data point was carried out in
triplicates.
2.5 | Protein extraction and immunoblotting
After treatment with rTNFα, in the presence or absence of baicalein,
AR42J cells were washed twice with cold PBS, lysed in RIPA buffer
(50mM Tris-HCl, 150mMNaCl, and 1%NP-40) containing proteinase
and phosphatase inhibitors, and then centrifuged at 12,000g for
10min at 4°C. The supernatants were collected and stored at
−80°C until analysis.
Nucleoprotein extraction was performed using the nucleoprotein
extraction kit according to the manufacturer's instructions (Sangon
Biotech, Shanghai, China). AR42J cells were washed twice with cold
PBS, lysed in cold hypotonic buffer for 10min and centrifuged at 800g
for 5min at 4°C. The pellet was collected and then lysed in cold lysis
buffer (with proteinase and phosphatase inhibitors), and then
centrifuged at 12,000g for 10min at 4°C. The supernatants were
collected and stored at −80°C until analysis.
Protein concentrations were determined using the Bradford
method. Samples were diluted to 3mg/ml with PBS and 5 × SDS-
PAGE sample loading buffer, and heated at 95°C for 5min before
loading. Thirty microgram of total protein were loaded per lane on
Invitrogen™ NuPAGE™ Bis-Tris gels (10%) and subsequently trans-
ferred to polyvinylidenedifluoride (PVDF) membranes (Millipore, MA).
Membranes were blocked with 5% (w/v) skimmed milk in TBST buffer
at room temperature for 2 hr, followed by incubation with specific
primary antibodies for β-actin, p-IκBα, IκBα, nucleus NF-κB p65
(n-p65), or cleaved-Notch 1 (c-Notch 1), overnight at 4°C. After
washing three times with TBST, membranes were subsequently
incubated with corresponding secondary antibodies conjugated with
horseradish peroxidase (1:10,000) for 2 hr at room temperature. Bound
antibodies were detected using an enhanced chemiluminescence (ECL)
system (Promega Corporation, Madison, WI), according to manufac-
turer's instructions. Luminescence intensities were quantified using
Imaging Systems analysis software (VersaDoc Mp5000, BIO-RAD).
2.6 | Measurement of TNFα and NO production
RAW264.7 cells were incubated with or without LPS in the absence or
presence of baicalein for 18 hr. The NO and TNFα concentrations in
culture medium were measured using the Griess reagent system and
mouse TNFα ELISA kit, respectively, according to the manufacture's
protocol. Macrophage-conditioned medium (CM) were as following:
Control-CM, RAW264.7 cells cultured in the absence of LPS;
LPS-CM, RAW264.7 cells cultured in the presence of LPS; Baicalein-
CM, RAW264.7 cells cultured in the presence of LPS and Baicalein.
CMs were collected, centrifuged at 1,500g for 10min., and the
supernatants stored at −80°C for further use.
2.7 | Statistical analysis
All experiments were performed in triplicate, and each experiment was
repeated at least three times. All values represent mean ± SD. Data
were analyzed by one-way analysis of variance and t-test was used for
comparison between any two groups. p value of <0.05 was considered
as statistic significant different.
3 | RESULTS
3.1 | Effect of baicalein on cell viability of AR42J and
RAW264.7
The viability of cultured cells was monitored using the MTT assay.
Treatment of AR42J cells for 5 days with different concentration of
baicalein or RAW274.7macrophages for 18 hr revealed nomeasurable
difference in viability for baicalein concentrations 5–40 μM compared
to control samples. However, at 80 μM, baicalein decreased the
viability of AR42J and RAW274.7 cells by approx. 30% (Figures 1a and
1B).
3.2 | Baicalein inhibits rTNFα induced ADM of
pancreatic acinar AR42J cells
Under normal culture conditions AR42J cell are predominantly
amylase positive acinar cells. When AR42J cells were treated with
50 ng/ml rTNFα, the phenotype ofAR42J progressively converted into
a ductal phenotype after 5 days exposure (Figure 2a). AR42J switched
phenotype from dominantly amylase-positive acinary cells (FITC
labeled) to dominant cytokeratin-19 (CK-19)—positive ductal cells
(TRITC labeled) compared to untreated amylase positive AR42J cells.
Concomitant treatment with baicalein, markedly reduced the fraction
of CK-19-positive population of ductal AR42J cells induced by rTNFα
treatment. Furthermore, decreased expression of amylase and CK-19
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(Amylase/CK-19) by baicalein in rTNFα-treated cells also demon-
strated the results (Figure 2b).
3.3 | Baicalein inhibits TNFα but not Hes-1 gene
expression in rTNFα-treated AR42J cells
TNFα can trigger the expression of various inflammatory mediators in
AR42Jcells (Robinson,Vona-Davis,Riggs, Jackson,&McFadden,2006;Sun
et al., 2007). To examine whether baicalein could inhibit the expression of
some inflammatorymediator, expression of TNFαmRNAwasmonitored by
RT-PCR analysis after 5 days exposure to rTNFα. TNFα expression was
significant increased after 5 days of rTNFα treatment compared to control
cells, and baicalein significantly inhibited this induction (Figure 3a). It was
reported, that the Notch target gene Hes-1 (hairy and enhancer of split 1)
was supregulated during ADM (Halbrook & Crawford, 2015). A significant
up-regulation of Hes-1 was also observed in rTNFα-treated AR42J cells;
however, baicalein had no effects on it upregulation (Figure 3b).
These results indicate that baicalein inhibits the expression TNFα
mRNA induced by rTNFα in AR42J cells, while it does not inhibit
rTNFα-induced and Notch-mediated Hes-1 expression.
3.4 | Baicalein prevents rTNFα induced IκBα
degradation and NF-κB translocation, but
not Notch activation in AR42J cells
To further investigate the mechanisms of baicalein inhibition of TNF-
induced ADM, we monitored the degradation of IκBα, the nuclear
translocation of the NF-κB subunit p65 and the cleavage of Notch 1
by Western blotting analysis of total cellular or nuclear extracts.
Treatment of AR42J cells with rTNFα, resulted in increased IκBα
FIGURE 1 Effect of baicalein on the viability of AR42J (a) and RAW264.7 cells (b). AR42J cells were treated with baicalein for 5 days, and
RAW264.7 cells for 18 hr, respectively. **p < 0.01
FIGURE 2 Effect of Baicalein on phenotypical switch of AR42J cells. (a) Immunofluorescence staining of amylase (green), CK-19(red), and
DAPI of AR42 cells. (b) Amylase and CK-19 protein expression monitored by Western blotting. (c) Quantification of amylase and CK-19
proteins detected by Western blotting (panel b). *p < 0.05 versus rTNFα treatment only; ##p < 0.01 versus control
4
htt
p:/
/do
c.r
ero
.ch
degradation, phosphorylation of IκBα (p-IκBα), and p65 translocation
to the nucleus (n-p65) (Figure 4a), which indicated that NF-κB signaling
pathwaywas activated by TNF treatment. CleavedNotch 1 (c-Notch 1)
expression was increased during ADM. Baicalein (40 μM) inhibited the
degradation of IκBα, phosphorylation of IκBα, and p65 translocation to
the nucleus. However, baicalein treatment did not inhibit the cleavage
of Notch-1. Effects on protein expression were consistent with the
observed gene expression results.
3.5 | Baicalein inhibits LPS-induced TNFα and NO
secretion in RAW264.7 cells and further inhibits
macrophage-conditioned medium induced
ADM in AR42J cells
Previous work demonstrated that inflammatory environment drives
ADM in pancreas, and that baicalein could attenuate the inflammatory
response of infiltrated macrophages (Fan et al., 2013; Strobel et al.,
2007). We investigated whether baicalein could attenuate LPS-
induced inflammatory response, and further inhibit AR42J ADM
induced by macrophage conditioned medium. Baicalein inhibited LPS-
induced NO production (Figure 5a) and TNF-α protein expression
(Figure 5b) in RAW264.7 cells. AR42J cells were treated with different
CM (Control-CM, LPS-CM, and LPS/Baicalein-CM) for 5 days and
phenotype switch was monitored by immunofluorescence double
staining for amylase and CK-19 (Figure 6a). LPS-CM induced AR42J
phenotype switch from amylase positive cells to CK-19 positive cells
was more pronounced than ADM induced by TNF alone. Only few
amylase positive (green) cells were detected in LPS-CM group. In the
LPS/Baicalein-CM treated group AR42J cells remained largely amylase
positive, and only rare CK-19 positive (red) cells were detected.
Changes in amylase and CK-19 protein levels were further confirmed
by Western blotting analysis (Figure 6b). This indicates that baicalein
FIGURE 3 Effect of Baicalein on rTNFα induced gene transcription in AR42J cells. AR42J cells were exposed to rTNFα for 5 days, and
TNFα (a) and Hes-1 (b) mRNA levels were measured by RT-PCR. **p < 0.01 versus rTNFα treatment only; ##p < 0.01 versus control
FIGURE 4 Effects of Baicalein on IκB degradation, IκBα phosphorylation, NF-κB p65 nuclear translocation, and Notch 1protein cleavage in
AR42J cells. (a) AR42J cells were stimulated with rTNFα and/or baicalein. Total and nuclear proteins were analyzed by Western blotting for
IκB, p-IκBα, NF-κB p65subunit, and intracellular Notch 1protein cleavage. (b) Quantitative analysis of protein expression. *p < 0.05 versus
rTNFα treatment only; **p < 0.01 versus rTNFα treatment only; ##p < 0.01 versus control.
5
htt
p:/
/do
c.r
ero
.ch
suppressed inflammation-mediated ADM of AR42J cells by inhibiting
LPS-induced macrophage cytokines secretion and suppressing ADM
response of AR42J cells to inflammation.
4 | DISCUSSION
Metaplasia is a reversible conversion of a differentiated tissue type into
another differentiated tissue in response to microenvironmental stress
conditions, including chronic inflammation (Lardon & Bouwens, 2005).
Themetaplasia of exocrine acinar tissue into ductal complexes (ADM) in
the pancreas has been observed in different pathological conditions,
most importantly in chronic pancreatitis patients. ADMwas reproduced
experimentally, in a caerulein-induced pancreatitis mouse model, and
in multiple transgenic mouse models (Grabliauskaite et al., 2015;
Guerra et al., 2007; Lowenfels &Maisonneuve, 2006). Metaplastic duct
cells are more likely accumulate gene mutations leading to cell cycle
disruption, loss of tumor suppressor and DNA repair genes and to
progress to pancreatic intraepithelial neoplasia (PanIN) first and invasive
PDAC later (Garcia-Carracedo et al., 2015; Shi et al., 2009). Many
cytokines and activated signaling pathways may drive ADM in the
inflammatory microenvironment. Previous work has shown that over-
expressionof growth factors in acinar cells, such as transforming growth
factor α (TGFα) or β (TGFβ), were required for the activation of Notch
signaling and the induction of ADM (De La O & Murtaugh, 2009;
Miyamoto et al., 2003). Notch signaling regulates cell growth and
differentiation in a wide variety of tissues. Notch pathway components
and Notch target genes are upregulated in PDAC precursors (including
metaplasia ductal cells) in both mouse and human, which indicates its
important role in ADM (De La O & Murtaugh, 2009). Recent study
FIGURE 5 Effects of baicalein on NO release (a), and secreation of TNF-α (b) in RAW264.7 cells supernatant. **p < 0.01 versus LPS
treatment only; ##p < 0.01 versus Control
FIGURE 6 Effect of CM on phenotype switch of AR42J. (a) Immunofluorescence staining of AR42J cells. Acinar phonetype is indicated by
amalyse positivity (green staining, control), ductal phenotype is indicated by CK-19 positivity (red staining). (b) The level of amylase and CK-19
protein expression. (c) Quantitative analysis of protein expression of amylase/CK-19. **p < 0.01 versus LPS-CM treatment only; ##p < 0.01
versus control
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showed that TNFα is overexpressed in pancreatitis and could induce
ADMin acinar cells throughNF-κBactivation (Liouet al., 2013). Further,
tumor cell- and macrophage–derived TNFα plays a profound role in
pancreatitis and pancreas malignancy, and inhibition of TNFα had a
protective effect (Egberts et al., 2008; Hughes et al., 1996). NF-κB is an
important signaling molecule that controls multiple cellular functions,
including the production of inflammatory cytokines, chemokines, and
adhesion molecules. Strong activation of NF-κB is observed in many
cancers including pancreatic cancer (Aggarwal & Gehlot, 2009). Clinical
data also demonstrated that NF-κB activation is more frequent in
pancreatic cancers associated with chronic pancreatitis (CPPCa) than in
sporadic cancers (Shimosegawa, Kume, & Satoh, 2009). Taken together
these observations indicate that TNFα and the activation of NF-κB are
relevant to the pathogenesis of ADM.
Inflammatory cells, especially macrophages, are important in
the progression of chronic pancreatitis (CP) and the associated
increases risk of developing PDAC. During CP, injured acinar cells
secreted chemokines to attract and activate macrophages, which
produce various cytokines, chemokines, prostaglandins, and TGFβ
to aggravate the CP or possibly induce carcinogenesis (Reding
et al., 2006). Geou-Yarh Liou's research showed that macrophage-
secreted cytokines such as TNFα and RANTES could drive ADM
through NF-κB activation in acinar cells (Liou et al., 2013).
Macrophage-targeted therapy has achieved good therapeutic
effects in the treatment of CP and PDAC (Ruffell & Coussens,
2015). Previous studied showed that baicalein, an active compound
isolated from S. baicalensis Georgi, exert anti-inflammatory, and
anti-tumor effects on CP and PDAC. Baicalein was shown to inhibit
the inflammatory response of acinar cells and macrophages in vivo
and in vitro (Li et al., 2015a; Zhou et al., 2017). Here we report
results from in vitro experiments aimed at characterizing the
effects of baicalein on ADM in pancreatic acinar cells induced by
rTNFα and macrophages.
On the one hand, our results indicated that baicalein inhibits
rTNFα-induced ADM, and this effect was associated with suppression
of NF-κB activation, but not of canonical Notch 1 activation. Previous
work showed that Notch 1 activation and the target gene expression
were the typical characteristic of ADM. Recent research demonstrated
that Notch 1 is not required for ADM in a Kras-induced PDAC model,
which proved that other signaling pathway (such as inflammatory
pathways) may have dominant effects on ADM (Avila, Troutman,
Durham, & Kissil, 2012). Our results suggest that inhibition of NF-κB
by baicalein could reduce ADM development under inflammatory
conditions. On the other hand, baicalein inhibited the secretion of
TNFα and NO of LPS induced RAW264.7, and further inhibited ADM
induction in pancreatic exocrine cells AR42J. The observation that CM
from baicalein-treated macrophages was less effective in inducing
ADM, suggesting the baicalein might also contribute to inhibit ADM
indirectly, by inhibiting the pro-inflammatory activity of macrophages.
In conclusion, our results revealed that baicalein, a natural
compound derived from Chinese herbal medicine, inhibits pancreatic
ADM progressions through two concurrent mechanisms: First, by
suppressing TNFα-induced NF-κB activation in pancreatic acinar cells
and, second, by inhibiting TNFα secretion by activated macrophages
(shown in Figure 7). The study provides new experimental evidence on
the potential of Chinese material medica therapy for the prevention or
treatment of CP and subsequent development of PDAC.
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FIGURE 7 The effects and mechanism of Baicalein on ADM. Macrophage-secreted cytokines, in particular TNFα, or recombinant TNFα
(rTNFα) drive pancreatic acinar-to-ductal metaplasia (ADM). NF-κB and Notch signals are activated during ADM. Baicalein directly reduced
rTNFα induced ADM of AR42J by inhibitibg NF-κB activation. Baicalein also suppresses the inflammatory response of macrophages and
improved the microenvironment, thereby indirectly inhibiting ADM of AR42J
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